1H,4H,5H,6H,7H,8H-cyclohepta[c]pyrazol-4-one, 97%, 5g

4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, 95.0%, 250mg

ethyl 1-isopropyl-3-nitro-1H-pyrazole-5-carboxylate, 98%, 10g

4-Chlorothieno[2,3-b]pyridine, 97%, 100mg

4-(aminomethyl)-1-methylpyrrolidin-2-one hydrochloride, 95.0%, 1g

Boc-(S)-3-Amino-3-(4-chlorophenyl)propionic acid, 95.0%, 5g

1-Cyclopentenecarboxylic acid, 98.0%, 5g

(S)-4-(tert-Butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 95.0%, 1g

Quinoxaline-2-carbonyl chloride, 95.0%, 5g

4-(furan-2-yl)-3,5,6,8,10,11-hexaazatricyclo[7.3.0.0�,?]dodeca-1,3,7,9,11-pentaen-7-amine, 96%, 50mg

o-Nitrotoluol, min. 99 %, zur Synthese, 1 l, Glasverpackung

(2-bromophenyl)[(tert-butoxycarbonyl)amino]acetic acid, 95.0%, 500mg

Millex®-Filtereinheiten 4 mm, unsteril, Porengr. 0,2 µm, hydrophobe PTFE Membran